ADORX THERAPEUTICS LTD has a total of 14 patent applications. It increased the IP activity by 300.0%. Its first patent ever was published in 2017. It filed its patents most often in United Kingdom, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are VALEAS SPA, AUTOPHAGYSCIENCES INC and HANGZHOU LEISUO PHARMACEUTICAL CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 10 | |
#2 | WIPO (World Intellectual Property Organization) | 2 | |
#3 | EPO (European Patent Office) | 1 | |
#4 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Moulton Ben | 4 |
#2 | Mccarthy Clive | 4 |
#3 | Lenagh-Snow Gabriel | 3 |
#4 | Macleod Calum | 3 |
#5 | Marlin Frédéric | 1 |
#6 | Mcmahon Pearl | 1 |
#7 | Rogers Joseph | 1 |
#8 | Walker Edward | 1 |
Publication | Filing date | Title |
---|---|---|
GB202019922D0 | Antagonist compounds | |
GB202019622D0 | Antagonist compounds | |
GB202016964D0 | Inhibitor compounds | |
GB202011996D0 | Antagonist compounds | |
GB202011892D0 | Antagonist compounds | |
GB201910865D0 | Antagonist compounds | |
GB201908511D0 | Hydroxamate compounds | |
GB201904158D0 | Antagonist compounds | |
GB201812604D0 | Antagonist compounds | |
GB201721751D0 | Compounds |